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Ehlers-Danlos syndrome type VI in a 17-year-old Iranian boy
with severe muscular weakness - a diagnostic challenge? 
Abstract
Background: The Ehlers-Danlos syndrome type VI (EDSVI) is an autosomal recessive connective tissue
disease which is characterized by severe hypotonia at birth, progressive kyphoscoliosis, skin
hyperelasticity and fragility, joint hypermobility and (sub-)luxations, microcornea, rupture of arteries
and the eye globe, and osteopenia. The enzyme collagen lysyl hydroxylase (LH1) is deficient in these
patients due to mutations in the PLOD1 gene.
Case Presentation: We report a 17-year-old boy, born to related parents, with severe kyphoscoliosis, scar
formation, joint hypermobility and multiple dislocations, muscular weakness, rupture of an ocular globe,
and a history of severe infantile hypotonia. EDS VI was suspected clinically and confirmed by an
elevated ratio of urinary total lysyl pyridinoline to hydroxylysyl pyridinoline, abnormal electrophoretic
mobility of the α-collagen chains, and mutation analysis.
Conclusion: Because of the high rate of consanguineous marriages in Iran and, as a consequence
thereof, an increased rate of autosomal recessive disorders, we urge physicians to consider EDS VI in
the differential diagnosis of severe infantile hypotonia and muscular weakness, a disorder which can
easily be confirmed by the analysis of urinary pyridinolines that is highly specific, sensitive, robust, fast,
non-invasive, and inexpensive. 
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Abstract 
Background: The Ehlers-Danlos syndrome type VI (EDSVI) is an autosomal recessive 
connective tissue disease which is characterized by severe hypotonia at birth, progressive 
kyphoscoliosis, skin hyperelasticity and fragility, joint hypermobility and (sub-)luxations, 
microcornea, rupture of arteries and the eye globe, and osteopenia. The enzyme collagen lysyl 
hydroxylase (LH1) is deficient in these patients due to mutations in the PLOD1 gene. 
Case Presentation: We report a 17-year-old boy, born to related parents, with severe 
kyphoscoliosis, scar formation, joint hypermobility and multiple dislocations, muscular 
weakness, rupture of an ocular globe, and a history of severe infantile hypotonia. EDS VI was 
suspected clinically and confirmed by an elevated ratio of urinary total lysyl pyridinoline to 
hydroxylysyl pyridinoline, abnormal electrophoretic mobility of the α-collagen chains, and 
mutation analysis.  
Conclusion: Because of the high rate of consanguineous marriages in Iran and, as a 
consequence thereof, an increased rate of autosomal recessive disorders, we urge physicians to 
consider EDS VI in the differential diagnosis of severe infantile hypotonia and muscular 
weakness, a disorder which can easily be confirmed by the analysis of urinary pyridinolines 
that is highly specific, sensitive, robust, fast, non-invasive, and inexpensive.  
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Introduction 
The Ehlers-Danlos syndrome is a heterogeneous 
group of inherited connective tissue disorders 
characterized by skin hyperelasticity and 
fragility, and joint hypermobility. They have 
been classified into types I (OMIM 130000), II 
(OMIM 130010), III (OMIM 130020), IV (OMIM 
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130050), VIIA and VIIB (OMIM 130060) with 
autosomal dominant inheritance and types VI 
(OMIM 225400), VIIC (OMIM 225410), and other 
types (OMIM 606408 and 612350) with 
autosomal recessive inheritance[1,2,3]. 
     The Ehlers-Danlos syndrome type VI (EDS VI), 
also called the kyphoscoliotic type[1], is 
characterized by severe hypotonia at birth, joint 
laxity, hyperextensible and fragile skin, severe 
progressive kyphoscoliosis, osteopenia, and 
rupture of arteries and of the eye globe[1,2]. The 
exact prevalence of EDS VI is unknown but 
estimated to be world-wide approximately 
1:100,000 live births[4].  
     EDS VI is caused by deficient lysyl hydroxylase 
(LH1)[5], an important posttranslational 
modifying enzyme of collagen synthesis due to 
mutations in the PLOD1 gene[6]. This enzyme 
catalyzes the hydroxylation of collagen lysyl 
residues to hydroxylysyl residues which are 
essential for the formation of stable collagen 
cross links, thus confining collagen its tensile 
strength; furthermore they are necessary for the 
attachment of galactosyl and glucosyl-galactosyl 
residues. A second, rarer form of EDS VI has 
been described, EDS VIB (as opposed to EDS 
VIA), in which patients have a similar clinical 
phenotype of EDS VI but with normal levels of 
LH1 activity, absence of mutations in PLOD1, and 
normal cross links. 
     Deficiency of LH1 gives rise to an abnormal 
pattern  of  lysyl  pyridinoline  (LP) and hydroxy- 
lysyl pyridinoline (HP) cross links formed in vivo 
and excreted in the urine[7]. The ratio of urinary 
total LP to HP in patients with EDS VI is much 
higher compared to normal controls[2,3,8]. Hence, 
we can take advantage of this finding and use it 
as an inexpensive tool for the diagnosis of EDS 
VI. At least 30 different mutations in the PLOD1 
gene have been identified (Giunta et al, in 
preparation). 
     Here we report a 17-year-old boy with typical 
clinical features, and biochemical and molecular 
findings of EDS VI, and emphasize the 
differential diagnosis of muscular disorders.  
Case Presentation 
This 17-year old boy is the first child of cousin 
parents once removed. The second and third 
children, a boy and girl, died at 1 year and 5 days 
of age, respectively, of unrelated cause. He was 
admitted to us for the evaluation of his muscular 
weakness. 
     Pregnancy, delivery at term, and neonatal 
adaptation were uneventful; his weight was 
3,000 grams but length and head circumference 
were not recorded. He developed hyper-
bilirubinemia during the first week after birth 
which required blood transfusion. 
             
                                                                    Fig. 1: Clinical aspects of the patient 
a: Face with down-slanting axis of the eyes (left); b: Kyphoscoliosis, hypotonic posture, and adiposity which is 
unrelated to EDS VI (middle); c: Skin over the right knee with scars and hyperkeratosis follicularis (right) 
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     Severe hypotonia was noticed since birth and 
kyphoscoliosis developed during the first 
months of life. Because of muscular weakness he 
had to be bottle-fed with a large-holed teat.      
     Gross motor development milestones were 
delayed. He could stand without support at 2 
years and started to walk at 2.5 years. He also 
had speech delay and could say his first words at 
the age of 20 months. He went to school for 5 
years but did not continue because of his motor 
disabilities. Although intelligence has not been 
formally evaluated, based on his relative good 
performance at school we believe that there is 
no mental retardation. He had a history of 
rupture of the ocular globe at age 15 years after 
his father's elbow accidentally hit his face, and of 
multiple dislocations of both wrists and ankles.     
On physical examination at the age of 17, his 
height, weight and head circumference were 165 
cm, 70 kg, and 55 cm, respectively. He had down-
slanting palpebral fissures (Fig. 1a), microcornea 
(9 mm in diameter as opposed to 11-12.5 mm in 
controls[2]), ptosis, prosthetic left eye, and 
slightly bluish sclera. The skin was soft, with 
multiple scars on knees due to poor healing, and 
with hyperkeratosis follicularis (Fig. 1c). He also 
had hypermobile joints; however, hyperelasticity 
of the skin was not prominent. Generalized 
hypotonia was noted and muscle strength was 
decreased. Muscle force was estimated to be 3-4 
(had active movement against gravity and some 
movement against resistance); however, reflexes 
and muscle bulk were normal. Skeletal survey 
revealed osteopenia, kyphoscoliosis, and 
platyspondyly of L3 (Fig. 2a) as well as 
distraction of the symphysis pubis and protrusio 
acetabuli (Fig. 2b), and downward slanting and 
thinning of the ribs (not shown). Bone mineral 
density (Norland XR-36) was normal in spine 
(0.991 mg/cm2) and hip (0.991 mg/cm2) but 
decreased in the femur (i.e., 0.810 mg/cm2 which 
is 1.2 SD below the age-matched reference). 
     Creatine phosphokinase, electromyogram, and 
nerve conduction velocity were normal. 
     Urine samples from the patient and parents 
were analyzed for urinary pyridinolines as 
reported[8]. The ratio of urinary total 
pyridinolines, lysyl pyridinoline to hydroxylysyl 
pyridinoline, in the patient was 7.1 (controls: 
0.20 ± 0.03; EDS VI: 5.99 ± 1.00[2]) and slightly 
increased (0.25 and 0.23) in the father and the 
mother, respectively, as also observed in other 
obligate heterozygotes[3]. 
     Electrophoretic mobility of the α- and β-
collagen chains of the various collagen types 
produced by cultured fibroblasts, performed as 
reported[9], was faster than normal which 
indicated that the lysyl residues were not 
hydroxylated and that there were no galactosyl 
and glucosyl-galactosyl residues attached. 
     Mutation analysis, performed as described[10], 
on DNA of the patient showed a novel 
homozygous non-sense mutation in exon 12 of 
the PLOD1 gene at position 1302 of the cDNA 
sequence (c.1302 C>G) which leads to a 
premature stop at amino acid position 434 
(p.Y434X; see also[11]). The parents were both 
heterozygous for the same mutation. 
   
    Fig. 2: Radiograms; a: Spine with scoliosis, osteopenia, and platyspondyly of L3  
b: Pelvis with distraction of the symphysis pubis and protrusio acetabuli 
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Discussion 
Severe muscular hypotonia and kyphoscoliosis 
at birth, generalized joint laxity, and rupture of 
the ocular globes are considered major 
diagnostic criteria for EDS VI whereas tissue 
fragility including atrophic scarring, easy 
bruising, arterial rupture, Marfanoid habitus, 
microcornea, radiographically considerable 
osteopenia, and positive family history are 
classified as minor diagnostic criteria for the 
disease[1]. Since severe muscular hypotonia, joint 
laxity and kyphoscoliosis – which are three of 
the major criteria for EDS VI – are also common 
findings in neuromuscular disorders such as 
Ullrich muscular dystrophy and Bethlem 
myopathy, physicians are often misled to suspect 
them in EDS VI patients.  
     Bethlem myopathy (OMIM 158810) and 
Ullrich muscular dystrophy (OMIM 254090) 
present with muscular weakness, 
hyperextensiblity of joints, and kyphoscoliosis 
and are caused by mutations in collagen type VI. 
     Bethlem myopathy is an autosomal dominant 
disease characterized by proximal muscular 
weakness and joint contractures mainly 
involving the elbows, ankles and fingers[14] 
whereas Ullrich congenital muscular dystrophy 
is transmitted in an autosomal recessive mode 
and is characterized by severe muscular 
weakness of early onset so that children usually 
never develop the ability to walk because of 
contractures of proximal joints and 
hypermobility of distal joints. Scar formation due 
to poor healing is also evident in these 
patients[15,16]. The similarities of these conditions 
and EDS VI are striking and comprise severe 
hypotonia, kyphoscoliosis, hypermobility of 
joints and fragile skin causing scar formation[12]. 
     Hence, extensive neuromuscular work-ups are 
performed usually in these patients yielding 
normal results before the diagnosis of EDS VI is 
considered[13]. 
     The clue that could help physicians 
distinguish between EDS VI and neuromuscular 
disorders, specifically Ullrich muscular 
dystrophy, is the presence of microcornea, a 
possible history of rupture of arteries and of 
ocular globe, and osteopenia. The hypermobility 
of   Ullrich  dystrophy  is  limited  to  distal  joints  
while in EDS VI all joints are involved.  
     Our patient had remained undiagnosed until 
the age of 17, despite the presence of all four 
major, as well as all minor criteria (except for 
arterial rupture). Only recently this patient was 
referred to us for consultation. Multiple organ 
involvements, such as skin, muscle, bone and 
eye, made a diagnosis difficult. Indeed, a 
neuromuscular disorder was initially suspected 
based on the combination of severe hypotonia, 
delayed motor development, kyphoscoliosis and 
multiple dislocations. However, the presence of a 
positive history for ocular globe rupture, of 
velvety skin, microcornea and osteopenia – a 
pattern specific for EDS VI – helped us to reach 
the correct diagnosis without having to perform 
an invasive neuromuscular workup. 
     Despite being considered a minor criterion, 
microcornea is a common finding in many of the 
previously reported EDS VI cases[2] as well as in 
our patient; osteopenia and recurrent joint 
dislocations are common findings, too, and were 
recorded in our patient as well. Ocular fragility is 
found in a minority of EDS VI individuals[2] and 
may lead to rupture of the globe after minor 
trauma as occurred in our patient. Vascular 
rupture, which is a life threatening complication, 
is absent in our patient at this age, and his 
parents were made aware of this potential 
complication later in life and were given advice 
in case of emergency for timely attending a 
hospital. 
Conclusion 
We suggest that physicians should consider EDS 
VI as one of the differential diagnoses in floppy 
infants and muscular weakness. The presence of 
positive findings such as microcornea, 
osteopenia, ocular rupture, arterial rupture is 
specific for EDS VI and can lead to the correct 
diagnosis. If EDS VI is suspected analysis of 
urinary pyridinolines should be performed next 
to confirm the diagnosis. The pyridinoline 
analysis is a sensitive, specific, robust, quick, and 
inexpensive method that reliably rules in or out 
EDS VI and helps to avoid an invasive 
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neuromuscular work-up. In case of positive 
results further molecular testing is available to 
identify the disease causing mutation(s) and 
thus allows offering prenatal diagnosis for future 
pregnancies. 
     To the best of our knowledge this is the first 
case report of EDS VI from Iran. Although the 
world-wide prevalence is estimated as low (~1 
in 100.000 live births[4]) it might be more 
frequent in Iran because many of the reported 
and unreported (Giunta et al. in prep.) cases 
originate from Turkey, Greece, and Middle East[4] 
countries in which consanguineous marriages 
are frequent. With this case report we hope to 
increase the awareness of this connective tissue 
disorder and to help in the work-up of muscular 
weakness. 
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